Annual EBITDA:
-$156.54M-$43.92M(-38.99%)Summary
- As of today, EWTX annual EBITDA is -$156.54 million, with the most recent change of -$43.92 million (-38.99%) on December 31, 2024.
- During the last 3 years, EWTX annual EBITDA has fallen by -$113.60 million (-264.53%).
- EWTX annual EBITDA is now -1497.20% below its all-time high of -$9.80 million, reached on December 31, 2019.
Performance
EWTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$42.04M+$3.36M(+7.40%)Summary
- As of today, EWTX quarterly EBITDA is -$42.04 million, with the most recent change of +$3.36 million (+7.40%) on June 30, 2025.
- Over the past year, EWTX quarterly EBITDA has dropped by -$4.47 million (-11.90%).
- EWTX quarterly EBITDA is now -1210.57% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$172.19M-$4.47M(-2.67%)Summary
- As of today, EWTX TTM EBITDA is -$172.19 million, with the most recent change of -$4.47 million (-2.67%) on June 30, 2025.
- Over the past year, EWTX TTM EBITDA has dropped by -$38.10 million (-28.42%).
- EWTX TTM EBITDA is now -5267.49% below its all-time high of -$3.21 million, reached on March 31, 2020.
Performance
EWTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EWTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -39.0% | -11.9% | -28.4% |
| 3Y3 Years | -264.5% | -157.3% | -203.2% |
| 5Y5 Years | -1497.2% | -974.7% | -2318.4% |
EWTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -264.5% | at low | -132.3% | +7.4% | -178.3% | at low |
| 5Y | 5-Year | -1497.2% | at low | -974.7% | +7.4% | -2318.4% | at low |
| All-Time | All-Time | -1497.2% | at low | -1210.6% | +7.4% | -5267.5% | at low |
EWTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.04M(+7.4%) | -$172.19M(-2.7%) |
| Mar 2025 | - | -$45.41M(-1.1%) | -$167.72M(-7.1%) |
| Dec 2024 | -$156.54M(-39.0%) | -$44.91M(-12.8%) | -$156.54M(-8.0%) |
| Sep 2024 | - | -$39.83M(-6.0%) | -$144.96M(-8.1%) |
| Jun 2024 | - | -$37.57M(-9.8%) | -$134.09M(-10.5%) |
| Mar 2024 | - | -$34.23M(-2.7%) | -$121.39M(-7.8%) |
| Dec 2023 | -$112.63M(-58.4%) | -$33.33M(-15.1%) | -$112.63M(-11.2%) |
| Sep 2023 | - | -$28.95M(-16.4%) | -$101.28M(-12.0%) |
| Jun 2023 | - | -$24.88M(+2.3%) | -$90.42M(-10.4%) |
| Mar 2023 | - | -$25.46M(-15.8%) | -$81.88M(-15.1%) |
| Dec 2022 | -$71.12M | -$21.99M(-21.5%) | -$71.12M(-14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.10M(-10.8%) | -$61.88M(-9.0%) |
| Jun 2022 | - | -$16.34M(-11.1%) | -$56.79M(-11.7%) |
| Mar 2022 | - | -$14.70M(-15.3%) | -$50.86M(-18.4%) |
| Dec 2021 | -$42.94M(-152.5%) | -$12.74M(+2.1%) | -$42.94M(-17.7%) |
| Sep 2021 | - | -$13.01M(-25.0%) | -$36.49M(-55.4%) |
| Jun 2021 | - | -$10.41M(-53.6%) | -$23.48M(-38.3%) |
| Mar 2021 | - | -$6.78M(-7.7%) | -$16.98M(-26.6%) |
| Dec 2020 | -$17.01M(-73.5%) | -$6.29M(-60.9%) | -$13.41M(-88.4%) |
| Jun 2020 | - | -$3.91M(-21.9%) | -$7.12M(-121.9%) |
| Mar 2020 | - | -$3.21M | -$3.21M |
| Dec 2019 | -$9.80M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Edgewise Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of EWTX is -$156.54M
What is the all-time high annual EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual EBITDA is -$9.80M
What is Edgewise Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, EWTX annual EBITDA has changed by -$43.92M (-38.99%)
What is Edgewise Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of EWTX is -$42.04M
What is the all-time high quarterly EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly EBITDA is -$3.21M
What is Edgewise Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, EWTX quarterly EBITDA has changed by -$4.47M (-11.90%)
What is Edgewise Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of EWTX is -$172.19M
What is the all-time high TTM EBITDA for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM EBITDA is -$3.21M
What is Edgewise Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, EWTX TTM EBITDA has changed by -$38.10M (-28.42%)